In agreement with this prediction, the systemic application of OPG leads to a decrease in tumor burden [8], and Corey and colleagues [9] demonstrated that OPG produced locally by cancer cells has a similar anti-metastatic effect. This evidence concerns the gene TNFRSF11B and cancer.